Agios Pharmaceuticals (United States)

326 papers and 18.1k indexed citations i.

About

In recent decades, authors affiliated with Agios Pharmaceuticals (United States) have published 326 papers, which have received a total of 18.1k indexed citations. Scholars at this organization have produced 128 papers in Hematology, 117 papers in Molecular Biology and 110 papers in Genetics on the topics of Erythrocyte Function and Pathophysiology (75 papers), Acute Myeloid Leukemia Research (74 papers) and Cancer, Hypoxia, and Metabolism (55 papers). Their work is cited by papers focused on Molecular Biology (10.3k citations), Cancer Research (6.5k citations) and Genetics (4.1k citations). Authors at Agios Pharmaceuticals (United States) collaborate with scholars in United States, United Kingdom and France and have published in prestigious journals including Nature, Science and Cell. Some of Agios Pharmaceuticals (United States)'s most productive authors include Shinsan M. Su, Lenny Dang, Katharine Yen, Valeria R. Fantin, Edward M. Driggers, Shengfang Jin, Stefan Größ, Craig B. Thompson, Patrick S. Ward and Joshua D. Rabinowitz.

In The Last Decade

Fields of papers published by authors at Agios Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Agios Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Agios Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Agios Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Agios Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Agios Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agios Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at McGill University and Génome Québec Innovation Centre Breakdown of academic impact, for scholars at University System of Maryland Breakdown of academic impact, for scholars at BirdLife international Breakdown of academic impact, for scholars at Nvidia (United Kingdom) Breakdown of academic impact, for scholars at Swiss Vaccine Research Institute Breakdown of academic impact, for scholars at National Center for Complementary and Integrative Health Breakdown of academic impact, for scholars at Center of Regenerative Medicine in Barcelona Breakdown of academic impact, for scholars at Pinnacle Clinical Research